Cargando…
Capecitabine Regulates HSP90AB1 Expression and Induces Apoptosis via Akt/SMARCC1/AP-1/ROS Axis in T Cells
Transplant oncology is a newly emerging discipline integrating oncology, transplant medicine, and surgery and has brought malignancy treatment into a new era via transplantation. In this context, obtaining a drug with both immunosuppressive and antitumor effects can take into account the dual needs...
Autores principales: | Zhang, Sai, Fan, Shunli, Wang, Zhenglu, Hou, Wen, Liu, Tao, Yoshida, Sei, Yang, Shuang, Zheng, Hong, Shen, Zhongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970866/ https://www.ncbi.nlm.nih.gov/pubmed/35368874 http://dx.doi.org/10.1155/2022/1012509 |
Ejemplares similares
-
Capecitabine Can Induce T Cell Apoptosis: A Potential Immunosuppressive Agent With Anti-Cancer Effect
por: Zhang, Sai, et al.
Publicado: (2021) -
USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
por: Kosinsky, Robyn Laura, et al.
Publicado: (2019) -
SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021) -
Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021) -
HSP90AB1 Is a Host Factor Required for Transmissible Gastroenteritis Virus Infection
por: Song, Daili, et al.
Publicado: (2023)